Cargando…
A Randomized Controlled Trial of Disclosing Genetic Risk Information for Alzheimer’s Disease via Telephone
PURPOSE: Telephone disclosure of genetic test results can improve access to services. To date, studies of its impact have focused on return of Mendelian risk information, principally hereditary cancer syndromes. METHODS: In a multisite trial of Alzheimer’s disease genetic risk disclosure, asymptomat...
Autores principales: | Christensen, Kurt D., Uhlmann, Wendy R., Roberts, J. Scott, Linnenbringer, Erin, Whitehouse, Peter J., Royal, Charmaine D. M., Obisesan, Thomas O., Cupples, L. Adrienne, Butson, Melissa B., Fasaye, Grace-Ann, Hiraki, Susan, Chen, Clara A., Siebert, Uwe, Cook-Deegan, Robert, Green, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897910/ https://www.ncbi.nlm.nih.gov/pubmed/28726810 http://dx.doi.org/10.1038/gim.2017.103 |
Ejemplares similares
-
Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment
por: Christensen, Kurt D., et al.
Publicado: (2020) -
The goldilocks conundrum: Disclosing discrimination risks in informed consent
por: Prince, Anya E. R., et al.
Publicado: (2022) -
To disclose, or not to disclose? Context matters
por: Rahimzadeh, Vasiliki, et al.
Publicado: (2015) -
Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry
por: Jonassaint, Charles R., et al.
Publicado: (2010) -
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
por: Christensen, Kurt D., et al.
Publicado: (2015)